These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 12430733)
1. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. Mørk C; Wahl A; Moum T Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733 [TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. He Z; Lu C; Basra MK; Ou A; Yan Y; Li L J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712 [TBL] [Abstract][Full Text] [Related]
3. [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version]. Wang XL; Zhao TE; Zhang XQ Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):791-3. PubMed ID: 15555362 [TBL] [Abstract][Full Text] [Related]
4. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index. Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573 [TBL] [Abstract][Full Text] [Related]
5. Impact of psoriasis on quality of life in Iran. Aghaei S; Moradi A; Ardekani GS Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529 [TBL] [Abstract][Full Text] [Related]
6. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients. Zou Q; Luo Y; Hao D; Li M; Jihui C J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238 [TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis. He Z; Lu C; Ou A; Fang J; Wang D; Deng J; Zhang Z; Yu J Health Qual Life Outcomes; 2012 Apr; 10():37. PubMed ID: 22500772 [TBL] [Abstract][Full Text] [Related]
8. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study. Chaptini C; Quinn S; Marshman G Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650 [TBL] [Abstract][Full Text] [Related]
9. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Badia X; Mascaró JM; Lozano R Br J Dermatol; 1999 Oct; 141(4):698-702. PubMed ID: 10583119 [TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732 [TBL] [Abstract][Full Text] [Related]
11. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis. Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311 [TBL] [Abstract][Full Text] [Related]
12. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions. Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942 [TBL] [Abstract][Full Text] [Related]
13. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. De Korte J; Mombers FM; Sprangers MA; Bos JD Arch Dermatol; 2002 Sep; 138(9):1221-7; discussion 1227. PubMed ID: 12224984 [TBL] [Abstract][Full Text] [Related]
14. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043 [TBL] [Abstract][Full Text] [Related]
15. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis. Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451 [TBL] [Abstract][Full Text] [Related]
16. Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis. Safikhani S; Sundaram M; Bao Y; Mulani P; Revicki DA J Dermatolog Treat; 2013 Feb; 24(1):50-9. PubMed ID: 22007701 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis. Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Lennox RD; Leahy MJ Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673 [TBL] [Abstract][Full Text] [Related]
19. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire. Dauden E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Caloto MT; Nocea G; Roset M; Lara N Health Qual Life Outcomes; 2012 May; 10():56. PubMed ID: 22624984 [TBL] [Abstract][Full Text] [Related]
20. The Norwegian version of the Quality of Life Scale (QOLS-N). A validation and reliability study in patients suffering from psoriasis. Wahl A; Burckhardt C; Wiklund I; Hanestad BR Scand J Caring Sci; 1998; 12(4):215-22. PubMed ID: 10067647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]